Contact this trialFirst, we need to learn more about you.
Cannabinoid Receptor Agonist
EHP-101 for Systemic Sclerosis
Recruiting0 awardsPhase 2
Miami, Florida
This trial is testing a new drug for safety and effectiveness in treating a skin condition called systemic sclerosis.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.